nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP2D6—Vinorelbine—ovarian cancer	0.108	0.255	CbGbCtD
Ranolazine—CYP3A4—Topotecan—ovarian cancer	0.0972	0.23	CbGbCtD
Ranolazine—CYP3A4—Vinorelbine—ovarian cancer	0.0685	0.162	CbGbCtD
Ranolazine—CYP3A4—Paclitaxel—ovarian cancer	0.0481	0.114	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—ovarian cancer	0.0408	0.0964	CbGbCtD
Ranolazine—CYP3A4—Docetaxel—ovarian cancer	0.0348	0.0822	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—ovarian cancer	0.0259	0.0613	CbGbCtD
Ranolazine—Carvedilol—VEGFA—ovarian cancer	0.00202	0.689	CrCbGaD
Ranolazine—Oedema peripheral—Docetaxel—ovarian cancer	0.000988	0.00172	CcSEcCtD
Ranolazine—Connective tissue disorder—Docetaxel—ovarian cancer	0.000985	0.00172	CcSEcCtD
Ranolazine—Urethral disorder—Docetaxel—ovarian cancer	0.000983	0.00171	CcSEcCtD
Ranolazine—Renal failure acute—Doxorubicin—ovarian cancer	0.00098	0.00171	CcSEcCtD
Ranolazine—Pain in extremity—Epirubicin—ovarian cancer	0.000977	0.0017	CcSEcCtD
Ranolazine—Diplopia—Epirubicin—ovarian cancer	0.000977	0.0017	CcSEcCtD
Ranolazine—Nausea—Chlorambucil—ovarian cancer	0.000974	0.0017	CcSEcCtD
Ranolazine—Vision blurred—Paclitaxel—ovarian cancer	0.00097	0.00169	CcSEcCtD
Ranolazine—Hot flush—Doxorubicin—ovarian cancer	0.000967	0.00168	CcSEcCtD
Ranolazine—Visual impairment—Docetaxel—ovarian cancer	0.000966	0.00168	CcSEcCtD
Ranolazine—Dizziness—Topotecan—ovarian cancer	0.000966	0.00168	CcSEcCtD
Ranolazine—Tremor—Paclitaxel—ovarian cancer	0.000965	0.00168	CcSEcCtD
Ranolazine—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000958	0.00167	CcSEcCtD
Ranolazine—Angioedema—Paclitaxel—ovarian cancer	0.000941	0.00164	CcSEcCtD
Ranolazine—Eye disorder—Docetaxel—ovarian cancer	0.000937	0.00163	CcSEcCtD
Ranolazine—Cardiac disorder—Docetaxel—ovarian cancer	0.00093	0.00162	CcSEcCtD
Ranolazine—Vomiting—Topotecan—ovarian cancer	0.000928	0.00162	CcSEcCtD
Ranolazine—Vertigo—Paclitaxel—ovarian cancer	0.000925	0.00161	CcSEcCtD
Ranolazine—Syncope—Paclitaxel—ovarian cancer	0.000923	0.00161	CcSEcCtD
Ranolazine—Lethargy—Doxorubicin—ovarian cancer	0.000923	0.00161	CcSEcCtD
Ranolazine—Leukopenia—Paclitaxel—ovarian cancer	0.000922	0.00161	CcSEcCtD
Ranolazine—Rash—Topotecan—ovarian cancer	0.000921	0.0016	CcSEcCtD
Ranolazine—Dermatitis—Topotecan—ovarian cancer	0.00092	0.0016	CcSEcCtD
Ranolazine—Blood creatinine increased—Epirubicin—ovarian cancer	0.000916	0.0016	CcSEcCtD
Ranolazine—Headache—Topotecan—ovarian cancer	0.000915	0.00159	CcSEcCtD
Ranolazine—Palpitations—Paclitaxel—ovarian cancer	0.00091	0.00158	CcSEcCtD
Ranolazine—Angiopathy—Docetaxel—ovarian cancer	0.000909	0.00158	CcSEcCtD
Ranolazine—Vomiting—Melphalan—ovarian cancer	0.000909	0.00158	CcSEcCtD
Ranolazine—Dehydration—Epirubicin—ovarian cancer	0.000909	0.00158	CcSEcCtD
Ranolazine—Loss of consciousness—Paclitaxel—ovarian cancer	0.000905	0.00158	CcSEcCtD
Ranolazine—Diplopia—Doxorubicin—ovarian cancer	0.000904	0.00158	CcSEcCtD
Ranolazine—Pain in extremity—Doxorubicin—ovarian cancer	0.000904	0.00158	CcSEcCtD
Ranolazine—Mediastinal disorder—Docetaxel—ovarian cancer	0.000903	0.00157	CcSEcCtD
Ranolazine—Rash—Melphalan—ovarian cancer	0.000902	0.00157	CcSEcCtD
Ranolazine—Dermatitis—Melphalan—ovarian cancer	0.000901	0.00157	CcSEcCtD
Ranolazine—Cough—Paclitaxel—ovarian cancer	0.000898	0.00157	CcSEcCtD
Ranolazine—Asthenia—Vinorelbine—ovarian cancer	0.000896	0.00156	CcSEcCtD
Ranolazine—Arrhythmia—Docetaxel—ovarian cancer	0.000896	0.00156	CcSEcCtD
Ranolazine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000893	0.00156	CcSEcCtD
Ranolazine—Pruritus—Vinorelbine—ovarian cancer	0.000884	0.00154	CcSEcCtD
Ranolazine—Breast disorder—Epirubicin—ovarian cancer	0.000883	0.00154	CcSEcCtD
Ranolazine—Mental disorder—Docetaxel—ovarian cancer	0.000878	0.00153	CcSEcCtD
Ranolazine—Anxiety—Paclitaxel—ovarian cancer	0.000873	0.00152	CcSEcCtD
Ranolazine—Malnutrition—Docetaxel—ovarian cancer	0.000873	0.00152	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00087	0.00152	CcSEcCtD
Ranolazine—Nausea—Topotecan—ovarian cancer	0.000867	0.00151	CcSEcCtD
Ranolazine—Dry mouth—Paclitaxel—ovarian cancer	0.000857	0.00149	CcSEcCtD
Ranolazine—Nausea—Melphalan—ovarian cancer	0.000849	0.00148	CcSEcCtD
Ranolazine—Confusional state—Paclitaxel—ovarian cancer	0.000847	0.00148	CcSEcCtD
Ranolazine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000847	0.00148	CcSEcCtD
Ranolazine—Dehydration—Doxorubicin—ovarian cancer	0.000841	0.00147	CcSEcCtD
Ranolazine—Muscle spasms—Docetaxel—ovarian cancer	0.000839	0.00146	CcSEcCtD
Ranolazine—Eosinophilia—Epirubicin—ovarian cancer	0.000836	0.00146	CcSEcCtD
Ranolazine—Pancreatitis—Epirubicin—ovarian cancer	0.000828	0.00144	CcSEcCtD
Ranolazine—Shock—Paclitaxel—ovarian cancer	0.000827	0.00144	CcSEcCtD
Ranolazine—Dizziness—Vinorelbine—ovarian cancer	0.000826	0.00144	CcSEcCtD
Ranolazine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000826	0.00144	CcSEcCtD
Ranolazine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000824	0.00144	CcSEcCtD
Ranolazine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000823	0.00143	CcSEcCtD
Ranolazine—Breast disorder—Doxorubicin—ovarian cancer	0.000817	0.00142	CcSEcCtD
Ranolazine—Skin disorder—Paclitaxel—ovarian cancer	0.000816	0.00142	CcSEcCtD
Ranolazine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000812	0.00142	CcSEcCtD
Ranolazine—Pancytopenia—Epirubicin—ovarian cancer	0.000802	0.0014	CcSEcCtD
Ranolazine—Anorexia—Paclitaxel—ovarian cancer	0.000801	0.0014	CcSEcCtD
Ranolazine—Vomiting—Vinorelbine—ovarian cancer	0.000794	0.00138	CcSEcCtD
Ranolazine—Dysuria—Epirubicin—ovarian cancer	0.00079	0.00138	CcSEcCtD
Ranolazine—Rash—Vinorelbine—ovarian cancer	0.000788	0.00137	CcSEcCtD
Ranolazine—Dermatitis—Vinorelbine—ovarian cancer	0.000787	0.00137	CcSEcCtD
Ranolazine—Hypotension—Paclitaxel—ovarian cancer	0.000785	0.00137	CcSEcCtD
Ranolazine—Headache—Vinorelbine—ovarian cancer	0.000783	0.00136	CcSEcCtD
Ranolazine—Syncope—Docetaxel—ovarian cancer	0.000783	0.00136	CcSEcCtD
Ranolazine—Leukopenia—Docetaxel—ovarian cancer	0.000781	0.00136	CcSEcCtD
Ranolazine—Eosinophilia—Doxorubicin—ovarian cancer	0.000774	0.00135	CcSEcCtD
Ranolazine—Palpitations—Docetaxel—ovarian cancer	0.000771	0.00134	CcSEcCtD
Ranolazine—Loss of consciousness—Docetaxel—ovarian cancer	0.000767	0.00134	CcSEcCtD
Ranolazine—Pancreatitis—Doxorubicin—ovarian cancer	0.000766	0.00133	CcSEcCtD
Ranolazine—Weight decreased—Epirubicin—ovarian cancer	0.000764	0.00133	CcSEcCtD
Ranolazine—Cough—Docetaxel—ovarian cancer	0.000761	0.00133	CcSEcCtD
Ranolazine—Insomnia—Paclitaxel—ovarian cancer	0.00076	0.00132	CcSEcCtD
Ranolazine—Paraesthesia—Paclitaxel—ovarian cancer	0.000754	0.00131	CcSEcCtD
Ranolazine—Dyspnoea—Paclitaxel—ovarian cancer	0.000749	0.0013	CcSEcCtD
Ranolazine—Somnolence—Paclitaxel—ovarian cancer	0.000747	0.0013	CcSEcCtD
Ranolazine—Pancytopenia—Doxorubicin—ovarian cancer	0.000742	0.00129	CcSEcCtD
Ranolazine—Nausea—Vinorelbine—ovarian cancer	0.000742	0.00129	CcSEcCtD
Ranolazine—Renal failure—Epirubicin—ovarian cancer	0.00074	0.00129	CcSEcCtD
Ranolazine—Dyspepsia—Paclitaxel—ovarian cancer	0.00074	0.00129	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000738	0.00129	CcSEcCtD
Ranolazine—Dysuria—Doxorubicin—ovarian cancer	0.000731	0.00127	CcSEcCtD
Ranolazine—Decreased appetite—Paclitaxel—ovarian cancer	0.00073	0.00127	CcSEcCtD
Ranolazine—Dry mouth—Docetaxel—ovarian cancer	0.000727	0.00127	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000725	0.00126	CcSEcCtD
Ranolazine—Fatigue—Paclitaxel—ovarian cancer	0.000724	0.00126	CcSEcCtD
Ranolazine—Constipation—Paclitaxel—ovarian cancer	0.000719	0.00125	CcSEcCtD
Ranolazine—Haematuria—Epirubicin—ovarian cancer	0.000718	0.00125	CcSEcCtD
Ranolazine—Confusional state—Docetaxel—ovarian cancer	0.000718	0.00125	CcSEcCtD
Ranolazine—Epistaxis—Epirubicin—ovarian cancer	0.00071	0.00124	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—ovarian cancer	0.000707	0.00123	CcSEcCtD
Ranolazine—Shock—Docetaxel—ovarian cancer	0.000701	0.00122	CcSEcCtD
Ranolazine—Nervous system disorder—Docetaxel—ovarian cancer	0.000698	0.00122	CcSEcCtD
Ranolazine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000697	0.00121	CcSEcCtD
Ranolazine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000692	0.00121	CcSEcCtD
Ranolazine—Skin disorder—Docetaxel—ovarian cancer	0.000692	0.00121	CcSEcCtD
Ranolazine—Bradycardia—Epirubicin—ovarian cancer	0.000688	0.0012	CcSEcCtD
Ranolazine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000687	0.0012	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—ovarian cancer	0.000685	0.00119	CcSEcCtD
Ranolazine—Anorexia—Docetaxel—ovarian cancer	0.000679	0.00118	CcSEcCtD
Ranolazine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000673	0.00117	CcSEcCtD
Ranolazine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000668	0.00116	CcSEcCtD
Ranolazine—Urticaria—Paclitaxel—ovarian cancer	0.000668	0.00116	CcSEcCtD
Ranolazine—Oedema peripheral—Epirubicin—ovarian cancer	0.000666	0.00116	CcSEcCtD
Ranolazine—Hypotension—Docetaxel—ovarian cancer	0.000665	0.00116	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—ovarian cancer	0.000664	0.00116	CcSEcCtD
Ranolazine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000664	0.00116	CcSEcCtD
Ranolazine—Abdominal pain—Paclitaxel—ovarian cancer	0.000664	0.00116	CcSEcCtD
Ranolazine—Urethral disorder—Epirubicin—ovarian cancer	0.000663	0.00115	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—ovarian cancer	0.000657	0.00115	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—ovarian cancer	0.000652	0.00114	CcSEcCtD
Ranolazine—Insomnia—Docetaxel—ovarian cancer	0.000644	0.00112	CcSEcCtD
Ranolazine—Paraesthesia—Docetaxel—ovarian cancer	0.00064	0.00111	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—ovarian cancer	0.000637	0.00111	CcSEcCtD
Ranolazine—Dyspnoea—Docetaxel—ovarian cancer	0.000635	0.00111	CcSEcCtD
Ranolazine—Somnolence—Docetaxel—ovarian cancer	0.000633	0.0011	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—ovarian cancer	0.000632	0.0011	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—ovarian cancer	0.00063	0.0011	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—ovarian cancer	0.000628	0.00109	CcSEcCtD
Ranolazine—Dyspepsia—Docetaxel—ovarian cancer	0.000627	0.00109	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000622	0.00108	CcSEcCtD
Ranolazine—Decreased appetite—Docetaxel—ovarian cancer	0.000619	0.00108	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000618	0.00108	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000616	0.00107	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000615	0.00107	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000615	0.00107	CcSEcCtD
Ranolazine—Fatigue—Docetaxel—ovarian cancer	0.000614	0.00107	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—ovarian cancer	0.000613	0.00107	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—ovarian cancer	0.000613	0.00107	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000609	0.00106	CcSEcCtD
Ranolazine—Constipation—Docetaxel—ovarian cancer	0.000609	0.00106	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—ovarian cancer	0.000604	0.00105	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—ovarian cancer	0.000603	0.00105	CcSEcCtD
Ranolazine—Asthenia—Paclitaxel—ovarian cancer	0.000603	0.00105	CcSEcCtD
Ranolazine—Pruritus—Paclitaxel—ovarian cancer	0.000594	0.00104	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—ovarian cancer	0.000592	0.00103	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—ovarian cancer	0.000589	0.00103	CcSEcCtD
Ranolazine—Feeling abnormal—Docetaxel—ovarian cancer	0.000587	0.00102	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—ovarian cancer	0.000585	0.00102	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—ovarian cancer	0.000583	0.00102	CcSEcCtD
Ranolazine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000582	0.00101	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000581	0.00101	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—ovarian cancer	0.00058	0.00101	CcSEcCtD
Ranolazine—Angiopathy—Doxorubicin—ovarian cancer	0.000568	0.000989	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—ovarian cancer	0.000566	0.000986	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000564	0.000982	CcSEcCtD
Ranolazine—Abdominal pain—Docetaxel—ovarian cancer	0.000563	0.000981	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—ovarian cancer	0.000559	0.000974	CcSEcCtD
Ranolazine—Dizziness—Paclitaxel—ovarian cancer	0.000556	0.000968	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—ovarian cancer	0.000555	0.000966	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—ovarian cancer	0.000548	0.000955	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—ovarian cancer	0.000545	0.000949	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—ovarian cancer	0.000537	0.000935	CcSEcCtD
Ranolazine—Vomiting—Paclitaxel—ovarian cancer	0.000534	0.000931	CcSEcCtD
Ranolazine—Rash—Paclitaxel—ovarian cancer	0.00053	0.000923	CcSEcCtD
Ranolazine—Dermatitis—Paclitaxel—ovarian cancer	0.000529	0.000922	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—ovarian cancer	0.000529	0.000921	CcSEcCtD
Ranolazine—Syncope—Epirubicin—ovarian cancer	0.000528	0.00092	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—ovarian cancer	0.000527	0.000918	CcSEcCtD
Ranolazine—Headache—Paclitaxel—ovarian cancer	0.000526	0.000917	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—ovarian cancer	0.000524	0.000912	CcSEcCtD
Ranolazine—Palpitations—Epirubicin—ovarian cancer	0.00052	0.000906	CcSEcCtD
Ranolazine—Carvedilol—ABCB1—ovarian cancer	0.000518	0.177	CrCbGaD
Ranolazine—Loss of consciousness—Epirubicin—ovarian cancer	0.000517	0.000901	CcSEcCtD
Ranolazine—Cough—Epirubicin—ovarian cancer	0.000514	0.000895	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—ovarian cancer	0.000513	0.000894	CcSEcCtD
Ranolazine—Asthenia—Docetaxel—ovarian cancer	0.000511	0.00089	CcSEcCtD
Ranolazine—Pruritus—Docetaxel—ovarian cancer	0.000504	0.000878	CcSEcCtD
Ranolazine—Anxiety—Epirubicin—ovarian cancer	0.000499	0.00087	CcSEcCtD
Ranolazine—Nausea—Paclitaxel—ovarian cancer	0.000499	0.000869	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000498	0.000867	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—ovarian cancer	0.00049	0.000854	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—ovarian cancer	0.000489	0.000852	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—ovarian cancer	0.000488	0.000851	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—ovarian cancer	0.000487	0.000849	CcSEcCtD
Ranolazine—Confusional state—Epirubicin—ovarian cancer	0.000484	0.000844	CcSEcCtD
Ranolazine—Palpitations—Doxorubicin—ovarian cancer	0.000481	0.000838	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000479	0.000834	CcSEcCtD
Ranolazine—Cough—Doxorubicin—ovarian cancer	0.000475	0.000828	CcSEcCtD
Ranolazine—Shock—Epirubicin—ovarian cancer	0.000473	0.000823	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—ovarian cancer	0.000471	0.000821	CcSEcCtD
Ranolazine—Dizziness—Docetaxel—ovarian cancer	0.000471	0.00082	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—ovarian cancer	0.00047	0.000819	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—ovarian cancer	0.000467	0.000813	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000464	0.000809	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—ovarian cancer	0.000462	0.000805	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00046	0.000802	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—ovarian cancer	0.000458	0.000798	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—ovarian cancer	0.000453	0.00079	CcSEcCtD
Ranolazine—Vomiting—Docetaxel—ovarian cancer	0.000453	0.000789	CcSEcCtD
Ranolazine—Rash—Docetaxel—ovarian cancer	0.000449	0.000782	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—ovarian cancer	0.000449	0.000782	CcSEcCtD
Ranolazine—Dermatitis—Docetaxel—ovarian cancer	0.000449	0.000782	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—ovarian cancer	0.000448	0.000781	CcSEcCtD
Ranolazine—Headache—Docetaxel—ovarian cancer	0.000446	0.000777	CcSEcCtD
Ranolazine—Shock—Doxorubicin—ovarian cancer	0.000437	0.000762	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000436	0.000759	CcSEcCtD
Ranolazine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000435	0.000758	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—ovarian cancer	0.000434	0.000757	CcSEcCtD
Ranolazine—Skin disorder—Doxorubicin—ovarian cancer	0.000432	0.000752	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—ovarian cancer	0.000431	0.000751	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00043	0.000749	CcSEcCtD
Ranolazine—Dyspnoea—Epirubicin—ovarian cancer	0.000428	0.000746	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—ovarian cancer	0.000427	0.000744	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—ovarian cancer	0.000424	0.000738	CcSEcCtD
Ranolazine—Nausea—Docetaxel—ovarian cancer	0.000423	0.000737	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—ovarian cancer	0.000423	0.000737	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—ovarian cancer	0.000418	0.000727	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—ovarian cancer	0.000415	0.000724	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000415	0.000722	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—ovarian cancer	0.000414	0.000721	CcSEcCtD
Ranolazine—Constipation—Epirubicin—ovarian cancer	0.000411	0.000716	CcSEcCtD
Ranolazine—Insomnia—Doxorubicin—ovarian cancer	0.000402	0.0007	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—ovarian cancer	0.000399	0.000695	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—ovarian cancer	0.000396	0.00069	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—ovarian cancer	0.000396	0.00069	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—ovarian cancer	0.000395	0.000688	CcSEcCtD
Ranolazine—Propranolol—ABCB1—ovarian cancer	0.000394	0.134	CrCbGaD
Ranolazine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000393	0.000684	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—ovarian cancer	0.000391	0.000682	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—ovarian cancer	0.000386	0.000673	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000384	0.000668	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—ovarian cancer	0.000383	0.000668	CcSEcCtD
Ranolazine—Urticaria—Epirubicin—ovarian cancer	0.000382	0.000665	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—ovarian cancer	0.00038	0.000662	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—ovarian cancer	0.00038	0.000662	CcSEcCtD
Ranolazine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000366	0.000638	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000363	0.000633	CcSEcCtD
Ranolazine—Urticaria—Doxorubicin—ovarian cancer	0.000353	0.000615	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—ovarian cancer	0.000351	0.000612	CcSEcCtD
Ranolazine—Asthenia—Epirubicin—ovarian cancer	0.000345	0.0006	CcSEcCtD
Ranolazine—Pruritus—Epirubicin—ovarian cancer	0.00034	0.000592	CcSEcCtD
Ranolazine—Asthenia—Doxorubicin—ovarian cancer	0.000319	0.000556	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—ovarian cancer	0.000318	0.000553	CcSEcCtD
Ranolazine—Pruritus—Doxorubicin—ovarian cancer	0.000314	0.000548	CcSEcCtD
Ranolazine—Vomiting—Epirubicin—ovarian cancer	0.000305	0.000532	CcSEcCtD
Ranolazine—Rash—Epirubicin—ovarian cancer	0.000303	0.000528	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—ovarian cancer	0.000303	0.000527	CcSEcCtD
Ranolazine—Headache—Epirubicin—ovarian cancer	0.000301	0.000524	CcSEcCtD
Ranolazine—Dizziness—Doxorubicin—ovarian cancer	0.000294	0.000512	CcSEcCtD
Ranolazine—Nausea—Epirubicin—ovarian cancer	0.000285	0.000497	CcSEcCtD
Ranolazine—Vomiting—Doxorubicin—ovarian cancer	0.000283	0.000492	CcSEcCtD
Ranolazine—Rash—Doxorubicin—ovarian cancer	0.00028	0.000488	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—ovarian cancer	0.00028	0.000488	CcSEcCtD
Ranolazine—Headache—Doxorubicin—ovarian cancer	0.000278	0.000485	CcSEcCtD
Ranolazine—Nausea—Doxorubicin—ovarian cancer	0.000264	0.00046	CcSEcCtD
